Moreover, we demonstrated that miR-138-5p could directly regulate the expression of EZH2 and SIRT1, which have been proven to be involved in regulation of cisplatin resistance of ovarian cancer [36, 37]. The gene discussed is EZH2; the disease is ovarian carcinoma.